Form 4: Veracyte VP Jonathan Wygant Reports Stock Transaction
SEC Form 4 Filing
Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., reports the withholding of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On June 2, 2024, Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., had 1,087 shares of common stock withheld to cover tax obligations.
- This transaction was related to the vesting of restricted stock units granted on February 22, 2022, August 5, 2022, and March 6, 2023.
- The price per share for the transaction was $20.75.
- Following the transaction, Wygant beneficially owns 47,971 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard stock transaction for tax purposes; it doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Key Dates
| Date | Description |
|---|---|
| February 22, 2022 | Date of grant for 750 Restricted Stock Units. |
| August 5, 2022 | Date of grant for 714 Restricted Stock Units. |
| March 6, 2023 | Date of grant for 677 Restricted Stock Units. |
| June 2, 2024 | Date of stock withholding transaction. |
| June 4, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.